Q

uniQure NV
D

QURE

12.840
USD
-0.13
(-1.00%)
مغلق
حجم التداول
32,488
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
686,136,113
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    S
    SLDB
    -0.22000
    (-3.67%)
    5.77500 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.